Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 15, Issue 2, 2000, Pages 281-284

  Higham, M A ^a   Pride, N B ^a   Alikhan, A ^a   Morrell, N W ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive; Gone promoter polymorphism; Pulmonary disease; Turnout necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

AGED; FEMALE; GENE FREQUENCY; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033964299     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15b10.x     Document Type: Article

References (21)

1. Snider GL. Defining chronic obstructive pulmonary disease. In: Calverley P, Pride N, eds. Chronic Obstructive Pulmonary Disease. London, UK, Chapman & Hall, 1995; 1-8.
2. Redline S, Tishler PV, Lewitter FI, Tager IB, Munoz A, Speizer FE. Assessment of genetic and nongenetic influences on pulmonary function. Am Rev Respir Dis 1987; 135:217-222.
3. Saetta M, Stefano AD, Maestrelli P, et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147: 301-306.
4. Amrani Y, Panettieri RA, Frossard N, Bronner C. Activation of the TNFα-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am J Respir Cell Mol Biol 1996; 15: 55-63.
5. Emala CW, Kuhl J, Hungerford CL, Hirshman CA. TNF-alpha inhibits isoproterenol-stimulated adenylyl cyclase activity in cultured airway smooth muscle cells. Am J Physiol 1997; 272: L644-L650.
6. Sun G, Stacey MA, Vittori E, et al. Cellular and molecular characteristics of inflammation in chronic bronchitis. Eur J Clin Invest 1998; 28: 364-372.
7. Mueller R, Chanez P, Campbell AM, Bousquet J, Heusser C, Bullock GR. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med 1996; 90: 79-85.
8. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
9. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
10. Wilson AG, Symons JA; McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
11. Huang S-L, Su C-H, Chang S-C. Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436-1439.
12. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Diagnosis and management of stable COPD. Thorax 1997; 52 (Suppl. 5): S7-S15.
13. European Respiratory Society. Standardized lung function testing. Eur Respir J 1993; 6 (Suppl. 6): 1-100.
14. Wilson AG, di Giovane FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992; 1: 353.
15. Pride NB, Burrows B. Development of impaired lung function: natural history and risk factors. In: Calverley P, Pride NB, eds. Chronic Obstructive Pulmonary Disease. London, UK, Chapman & Hall, 1995; pp. 69-91.
16. Kubota T, McNamara D, Wang JJ, et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. Circulation 1998; 97: 2499-2501.
17. Rudwaleit M, Tikly M, Khamashata M, et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725-1728.
18. Chen CJ, Yen JH, Tsai WC, et al. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett 1997; 55: 1-3.
19. Fong KY, Howe HS, Tin SK, Boey ML, Feng PH. Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore 1996; 25: 90-93.
20. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Greenan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 1995; 12: 127-133.
21. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.